This content is from: Innovation

JLL Sells PharmaNet Development

New York-based JLL Partners has sold its drug development services company PharmaNet Development Group.

New York-based JLL Partners has sold its drug development services company PharmaNet Development Group. Financial terms of the deal have not been disclosed.

inVentiv Health, a unit of Thomas H Lee Partners, has bought the firm. JLL, a private equity investment firm with nearly $4 billion under management, purchased PharmaNet in 2009.

Click here for the release from PR Newswire.

Related Content